US

Peter A Schneider

This inventor holds 0 USPTO granted patents, plus 3 CIPO patents.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Peter A Schneider. Retrieved from https://idiyas.com/inventor/peter-a-schneider-v82xmheo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0


Loading Chart...

Title: Peter A Schneider - Innovator in Medical Devices

Introduction

Peter A Schneider is a notable inventor in the field of medical devices, particularly known for his contributions to treating atherosclerotic occlusive disease. His innovative approach has the potential to significantly improve patient outcomes in vascular treatments.

Latest Patents

Peter A Schneider holds a patent for a device and method for tacking plaque to the blood vessel wall. This plaque tack device is designed as a thin, annular band made from durable, flexible material. It features a plurality of barbs or anchoring points on its outer periphery, which help prevent dislodgment during medical procedures. The device can be utilized in conjunction with balloon angioplasty or as a standalone treatment to reopen blocked blood vessels.

Career Highlights

Throughout his career, Peter has worked with several companies, including Innovasc LLC and Intact Vascular, Inc. His experience in these organizations has allowed him to refine his skills and contribute to advancements in medical technology.

Collaborations

[This section has been skipped due to space constraints.]

Conclusion

Peter A Schneider's work in developing innovative medical devices showcases his commitment to improving healthcare solutions. His contributions have the potential to make a significant impact on the treatment of vascular diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…